Physician profile
Colleen E Brown
NPI 1790096774
$488.83
in general payments reported to CMS, 2019-2025
13 companies · $122 in 2025
The $122 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.53 · 2020: $112 · 2021: $147 · 2022: $39.39 · 2023: $33.18 · 2024: $23.57 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $178.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $122.19 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Boston Scientific Corporation | $69.26 | 2020-2023 | Watchman Access System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $61.72 | 2019-2025 | Xifaxan |
| Lilly USA, LLC | $45.88 | 2020-2021 | |
| Amarin Pharma, INC. | $38.20 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $31.48 | 2021 | |
| Gilead Sciences, INC. | $26.16 | 2025 | |
| Janssen Pharmaceuticals, INC | $25.23 | 2021 | |
| Optinose US, INC. | $17.74 | 2022 | |
| Amgen INC. | $14.28 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.03 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $12.28 | 2021 | |
| Ironwood Pharmaceuticals, INC | $11.38 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colleen Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.